Showing results (391-400 of 2,442) with videos related to

Sort By:
Pageof 245
Diabetology & Metabolic Syndrome|October 4, 2025
Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patientsMing-Hsun Lin, Ren-Hua Ye, Hong-Jie Jhou, et al.
Diabetology & Metabolic Syndrome|September 27, 2025
Mediation of fasting blood glucose between relative muscle strength and hypertension: insights from two cohortsPengyu Wang, Li Huang, Zhou Zhu, et al.
Diabetology & Metabolic Syndrome|September 1, 2021
A potent weighted risk model for evaluating the occurrence and severity of diabetic foot ulcersLu Shi, Huiyi Wei, Tianxiao Zhang, et al.
Diabetology & Metabolic Syndrome|August 19, 2025
Unveiling the impact of bisphenol a exposure on gene expression and immune response in diabetic nephropathy through integrative toxicogenomics and molecular dynamics approachesYan Zhang, Shan Lu, Yijun Dong, et al.
Diabetology & Metabolic Syndrome|August 15, 2025
Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progressionNarainrit Karuna, Lauren Kerrigan, Kevin Edgar, et al.
Diabetology & Metabolic Syndrome|August 18, 2025
Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategiesWenwen Zheng, Qianxian Qi, Jie Li, et al.
Diabetology & Metabolic Syndrome|August 18, 2025
AI-driven prediction of insulin resistance in non-diabetic populations using minimal invasive tests: comparing models and criteriaWeihao Gao, Zhuo Deng, Zheng Gong, et al.
Diabetology & Metabolic Syndrome|August 18, 2025
Switching to insulin degludec/aspart penfill reusable cartridges in patients with type 2 diabetes mellitus: real-life outcomesSezin Dogan Çakır, Hatice Deniz Yücel, Zeynep Akgül Kızılçay, et al.
Diabetology & Metabolic Syndrome|August 18, 2025
Impact of phytosterol supplementation on metabolic syndrome factors: a systematic review of randomized controlled trialsFaezeh Ghanbari-Gohari, Mohammad Khaksari, Ahmad Naghibzadeh-Tahami, et al.
Diabetology & Metabolic Syndrome|August 7, 2025
Empagliflozin targeted the immune-related gene PIK3CA in type 2 diabetes mellitus treatment: network pharmacology analysis and experimental evidenceHeng Zhong, Guo-Juan Sun, Fu-Man Du, et al.
Pageof 245